Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-12
2005-04-12
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S306000, C514S859000, C514S294000, C546S094000, C546S154000, C546S159000
Reexamination Certificate
active
06878713
ABSTRACT:
This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs and pseudopolymorphs thereof, to their preparation, to their compositions and to their use.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3924042 (1975-12-01), Gerster et al.
patent: 3984403 (1976-10-01), Fujisawa et al.
patent: 3985882 (1976-10-01), Gerster et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4051247 (1977-09-01), Schuppan et al.
patent: 4382892 (1983-05-01), Hayakawa et al.
patent: 4399134 (1983-08-01), Ishikawa et al.
patent: 4404207 (1983-09-01), Stern
patent: 4416884 (1983-11-01), Ishikawa et al.
patent: 4443447 (1984-04-01), Gerster et al.
patent: 4472406 (1984-09-01), Gerster et al.
patent: 4472407 (1984-09-01), Stern et al.
patent: 4535161 (1985-08-01), Hayakawa et al.
patent: 4552879 (1985-11-01), Ishikawa et al.
patent: 4563459 (1986-01-01), Grohe et al.
patent: 4594347 (1986-06-01), Ishikawa et al.
patent: 4599418 (1986-07-01), Irikura et al.
patent: 4638067 (1987-01-01), Culbertson et al.
patent: 4642355 (1987-02-01), Nakamura et al.
patent: 4665079 (1987-05-01), Culbertson et al.
patent: 4777175 (1988-10-01), Culbertson et al.
patent: 4822801 (1989-04-01), Domagala et al.
patent: 4874764 (1989-10-01), Ueda et al.
patent: 4880806 (1989-11-01), Ueda et al.
patent: 4894458 (1990-01-01), Masuzawa et al.
patent: 4935420 (1990-06-01), Ueda et al.
patent: 4997943 (1991-03-01), Iwata et al.
patent: 5051509 (1991-09-01), Nagano et al.
patent: 5097032 (1992-03-01), Domagala et al.
patent: 5185337 (1993-02-01), Fujii et al.
patent: 5290934 (1994-03-01), Ueda et al.
patent: 5348961 (1994-09-01), Iwata et al.
patent: 5420140 (1995-05-01), Perrin
patent: 5436367 (1995-07-01), Iwata et al.
patent: 5607942 (1997-03-01), Petersen et al.
patent: 5639886 (1997-06-01), Zerbes et al.
patent: 5677316 (1997-10-01), Ao et al.
patent: 5859026 (1999-01-01), Ito et al.
patent: 5869661 (1999-02-01), Ochi et al.
patent: 5889009 (1999-03-01), Miyake et al.
patent: 6034100 (2000-03-01), Adachi et al.
patent: 6121285 (2000-09-01), Takemura et al.
patent: 6136806 (2000-10-01), Hittel
patent: 6184388 (2001-02-01), Takemura et al.
patent: 6329391 (2001-12-01), Ledoussal et al.
patent: 6514986 (2003-02-01), de Souza et al.
patent: 0230295 (1987-07-01), None
patent: 0241206 (1987-10-01), None
patent: 0287951 (1988-10-01), None
patent: 0300735 (1989-01-01), None
patent: 0304087 (1989-02-01), None
patent: 0342675 (1989-11-01), None
patent: 0541086 (1993-05-01), None
patent: 0572259 (1993-12-01), None
patent: 0394553 (1995-06-01), None
patent: 0908181 (1999-04-01), None
patent: 0919553 (1999-06-01), None
patent: 57081486 (1982-05-01), None
patent: 57176987 (1982-10-01), None
patent: 58090511 (1983-05-01), None
patent: 63192753 (1988-08-01), None
patent: 02131483 (1990-05-01), None
patent: 02188570 (1990-07-01), None
patent: 02188589 (1990-07-01), None
patent: 05339238 (1993-12-01), None
patent: 6-145167 (1994-05-01), None
patent: 9414794 (1994-07-01), None
patent: 9415938 (1994-07-01), None
patent: 9420105 (1994-09-01), None
patent: 9724128 (1997-07-01), None
patent: 9731000 (1997-08-01), None
patent: 9744034 (1997-11-01), None
patent: 9858923 (1998-12-01), None
patent: 9914214 (1999-03-01), None
patent: 9926940 (1999-06-01), None
patent: 0018404 (2000-04-01), None
patent: 0068229 (2000-11-01), None
patent: WO 0068229 (2000-11-01), None
patent: 0185095 (2001-11-01), None
patent: 0185728 (2001-11-01), None
patent: 0209758 (2002-02-01), None
Takei, CA 136:147733, 2001.*
Nishijima, CA 136:2738, 2000.*
Yamada, CA 134:141378, 2000.*
Yamada, CA 134:141377, 2000.*
Kurokawa, CA 135:300896, 2000.*
Kurokawa, CA 130:322834, 1999.*
Fujio, CQA 129:339430, 1998.*
Gollnick, CA 129:310840, 1998.*
Cooper, J. Med. Chem., VOI 35, pp 1392-1398, 1992.*
Frank, CA 129:245024, 1998.*
Frank, CA 129:239390, 1998.*
Xiong, CA 127:358825, 1997.*
Klopman, CA 123:164953, 1993.*
Sanchez, CA 124:86783, 1995.*
Miyamoto, CA 124:170377, 1995.*
Hashimoto, CA 124:343084, 1996.*
Escribano, CA 127:302924, 1997.*
Yang, CA 131:153420, 1999.*
Alsina J. et al. “Active Carbonate Resins for Solid-Phase Synthesis Through the Anchoring of a Hydroxyl Function. Synthesis of Cyclic and Alcohol Peptides”,Tetrahedron Letters, (1997), 35(5):883-886.
Edwards W.B. et al. “Generally Applicable, Convenient Solid-Phase Synthesis and Receptor Affinities of Octreotide Analogs”,J. Med. Chem., (1994), 37(22):3749-3757.
Dhople, A.M. and M.A. Tbanez. “In vivo susceptibility of mycobacterium leprae to ofloxacin either singly or in combination with Rifampicin and Rifabutin”,Arzneimittel-Forschung., (1994), 44(4): 563-565.
Haustein U.F. et al. “Topical quinolone nadifloxacin (OPC-7251) in bacterial skin disease: clinical evaluation in a multicenter open trial and in vitro antimicrobiological susceptibility testing”,J. Dermatological Treatment, (1997), 8: 87-92.
Hashimoto, Koji et al. “A Practical Synthesis of (S)-(−)-Nadifloxacin: Novel Acid-Catalyzed Racemization of Tetrahydroquinaldine Derivative”,Chem. Pharm. Bull., (1996), 44(4):642-645.
Irish, D. et al. “Control of an outbreak of an epidemic methicillin-resistantStaphylococcus aureusalso resistant to mupirocin”,J. Hospital Infection, (1998), 39: 19-26.
Kido, M. et al. “Crystal Structures of Nadifloxacin Anhydride and its Hemihydrate”,Chem. Pharm. Bull., (1994), 42(4):872-876.
Takahashi et al. “Reduction of in vitro Clastogenicity Induced by the Mixture of Optical Isomers of Nadifloxacin during Storage”,Arzneim.-Forsch./Drug Res.,(1995), 45(1): 195-197.
Sloan et al. “Definition and attainment of high purity of organic compounds”, Chapter 2, 179-182,Physics and Chemistry of the Organic Solid State, eds. D. Fox, Labes and Weissberer. Interscience Publishers, London, 1963.
Morita, S. et al. “An efficient synthesis of a key determinate towards (S)-(−)-Nadifloxacin”,Tetrahedron: Asymmetry, (1995), 6(1): 245-254.
Morita, S. et al. “Synthesis and Antibacterial Activity of the Metabolites of 9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid (OPC-7251)”,Chem. Pharm. Bull., (1990), 38(7): 2027-2029.
Ishikawa, H. et al. “Studies on Antibacterial agents. I. Synthesis of Substituted 6,7-Dihydro-1-oxo-1H,5H-benzo[i,j]-quinolizine-2-carboxylic acids”,Chem. Pharm. Bull., (1989), 37(8): 2103-2108.
English translation of Yamada, Hirao et al. “Evaluation of the in vitro drug efficacy of Nadifloxacin Cream”,Iyakuhin Kenkyu, (2000), 31(8): 519-524.
English abstract of Japanese patent 02131483, dated May 21, 1990.
English abstract of Japanese patent 02188589, dated Jul. 24, 1990.
English translation of Yamada, Hiroaki, et al. “Bioequivalency of 1% Nadifloxacin lotion and 1% of Nadifloxacin cream”,Iyakuhin Kenkyu, (2000), 31(8):525-528.
Berge, Stephen M. et al. “Pharmaceutical Salts”,J. Pharmaceutical Sciences, (1977), 66(1): 1-19.
Abstract of Koike, M. et al.Iyakuhin Kenkyu, (1990), 21(5): 998-1021.
Abstract of Koike, M. et al.Iyakuhin Kenkyu, (1990), 21(5): 1022-1033.
Abstract of Fujita, S. et al.Iyakuhin Kenkyu, (1990), 21(6): 1156-1176.
Abstract of Koike, M. et al.Yakubutsu Dotai, (1990), 5(2): 199-208.
Abstract of Yasuo, A. et al.Yakuri to Chiryo, (1990), 18(4): 1717-1730.
Abstract of Hayakawa, R. et al.Hifu, (1990), 32(2): 217-230.
Abstract of Asada, Y. et al.Yakuri to Chiryo, (1990), 18(4): 1717-1730.
Abstract of Awogi, T. et al.Iyakuhin Kenkyu, (1990), 21(4): 626-635.
Abstract of Matsuzawa, A. et al.Iyakuhin Kenkyu, (1990), 21(4): 636-646.
Abstract of Nagao, T. et al.Iyakuhin Kenkyu, (1990), 54(4)
Agarwal Shiv Kumar
Chugh Yati
De Souza Noel John
Deshpande Prasad Keshav
Nair Sheela Chandrasekharan
Seaman D. Margaret
Wockhardt Limited
LandOfFree
Generation triple-targeting, chiral, broad-spectrum... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Generation triple-targeting, chiral, broad-spectrum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Generation triple-targeting, chiral, broad-spectrum... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3384928